Athersys Inc (ATHX.OQ)
ATHX.OQ on NASDAQ Stock Exchange Capital Market
1.59USD
2:21pm EDT
1.59USD
2:21pm EDT
Price Change (% chg)
$-0.01 (-0.62%)
$-0.01 (-0.62%)
Prev Close
$1.60
$1.60
Open
$1.60
$1.60
Day's High
$1.60
$1.60
Day's Low
$1.58
$1.58
Volume
3,318
3,318
Avg. Vol
53,423
53,423
52-wk High
$2.41
$2.41
52-wk Low
$0.95
$0.95
About
Athersys Inc. is a biopharmaceutical company engaged in the field of regenerative medicine. During the year ended December 31, 2011 the Company is developing its platform product, MultiStem, a allogeneic stem cell product that has been evaluated in two completed Phase I clinical trials and as of December 31, 2011, is being... (more)
Overall
| Beta: | 1.63 |
| Market Cap (Mil.): | $90.09 |
| Shares Outstanding (Mil.): | 56.30 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ATHX.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 44.65 | 37.87 |
| EPS (TTM): | -0.49 | -- | -- |
| ROI: | -127.66 | -2.30 | 18.70 |
| ROE: | -188.28 | -2.12 | 19.53 |
Competitors
| Price | Change | |
|---|---|---|
| Roche Holding Ltd. (ROG.VX) | CHF228.70 | +0.70 |
| Abbott Laboratories (ABT.N) | $36.75 | -0.09 |
| Sanofi SA (SASY.PA) | €76.36 | -0.49 |
| Merck & Co., Inc. (MRK.N) | $48.46 | -0.12 |
| Arena Pharmaceuticals, Inc. (ARNA.OQ) | $6.97 | +0.10 |
| Bristol Myers Squibb Co. (BMY.N) | $43.82 | -0.17 |
| Bristol Myers Squibb Co. (BMYMP.PK) | -- | -- |
| GlaxoSmithKline plc (GSK.L) | 1,712.50p | 0.00 |
| Eli Lilly & Co. (LLY.N) | $53.79 | +0.29 |
| Orexigen Therapeutics, Inc. (OREX.OQ) | $7.55 | +0.01 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Wright Reports
|
$460.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

